More News

Cancer immunotherapy and gene therapy in a single nanoparticle

Jim Cornall -
Cancer cells survive by hiding from the immune system's surveillance. A KAIST research team has developed a new anticancer...

New data from DM1 study

Jim Cornall -
Arthex Biotech has published new preclinical data demonstrating central nervous system (CNS) activity of its investigational antimiR-23b therapy, ATX-01,...

Synaptiq Therapeutics launches with acquisition of SYN-001 programme

Jim Cornall -
A consortium of European and US-based investors and Nobias Therapeutics has launched Synaptiq Therapeutics, a privately held, clinical-stage biotechnology...

Collaboration to develop first medicine for newly identified ReNU syndrome

Jim Cornall -
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and n-Lorem Foundation, a nonprofit, have announced a strategic collaboration and global exclusive license...

Body’s natural recycling system could help reduce inflammation

Jim Cornall -
Researchers at VIB and KU Leuven in Belgium, together with international collaborators, have discovered that blocking autophagy – the...

Crystalys Therapeutics raises $130m for gout treatment

Jim Cornall -
Crystalys Therapeutics Inc. has closed an oversubscribed $130m Series B financing to support the late-stage global clinical development and...

Boost to biotech in Virginia with lab capacity increase

Jim Cornall -
Activation Capital, the operating name of the Virginia Biotechnology Research Partnership Authority, has expanded its Bio+Tech Center to support...

AI and sleep analysis help early diagnosis of Alzheimer’s

Jim Cornall -
Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public...

Taiwan positions itself as global biotech innovation partner at BIO Asia-Taiwan 2026

Jim Cornall -
BIO Asia–Taiwan 2026, Asia's largest biotechnology gathering jointly organized by Taiwan Bio Industry Organization (Taiwan BIO) and the global...

KAIST gives antibodies ‘eyes’ to detect cancer

Jim Cornall -
Antibodies find and attack cancer cells, but cancer-causing mutations inside cells have remained a blind spot for treatment because...

GHIT Fund invests in portable rapid diagnostic system for Ebola disease

Jim Cornall -
The Global Health Innovative Technology (GHIT) Fund has announced an investment of approximately $862,000 in a project to develop...

New weak spot linked to DNA repair in aggressive, drug-resistant cancers

Jim Cornall -
A new way for hard-to-treat cancer cells to protect themselves from being killed by anti-cancer drugs has been found. The...

Base to Base biotech podcast 69: nrHSV-1 technology and environmental testing through hair

Jim Cornall -
This week, we have conversations with LinusBio founder and Mt. Sinai environmental professor, Dr. Manish Arora, as well as...

Novel smart mRNA harnesses pre-existing immunity in 99% of world population

Jim Cornall -
CancerVax, Inc., the developer of a universal cancer treatment platform that “tricks” the body’s immune system into fighting cancer,...

Asthma: New mechanism of action curbs asthma inflammatory response

Jim Cornall -
A team from the University of Bonn and the Research Center Borstel, Leibniz Lung Center (FZB) has discovered a...

Alzheimer’s Drug Discovery Foundation and Michael J. Fox Foundation launch $5m partnership

Jim Cornall -
The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) have announced a...

New approach to developing non-opioid painkillers

Jim Cornall -
An international research team led by the Medical University of Vienna has investigated a new peptide derived from cone...

Atopic dermatitis trial meets primary endpoint

Jim Cornall -
InnoCare Pharma has announced that registrational phase III clinical study results of novel TYK2 (tyrosine kinase 2) inhibitor soficitinib...

Key to immunotherapy for intractable brain tumours discovered

Jim Cornall -
Researchers have uncovered a clue to why immune checkpoint inhibitors—cancer therapies that release the immune brakes exploited by tumours...

Fast Track Designation for colorectal cancer treatment

Jim Cornall -
SOTIO Biotech has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to...

AI helps predict which DNA sequences bind to each other

Jim Cornall -
Researchers have demonstrated a novel AI model that can predict which DNA molecules bind with which other DNA molecules....